Cargando…
Feasibility and efficacy of combined pancreatic islet‐lung transplantation in cystic fibrosis‐related diabetes–PIM study: A multicenter phase 1–2 trial
Cystic fibrosis‐related diabetes (CFRD) is a common complication of cystic fibrosis (CF), and restoring metabolic control in these patients may improve their management after lung transplantation. In this multicenter, prospective, phase 1–2 trial, we evaluate the feasibility and metabolic efficacy o...
Autores principales: | Rakotoarisoa, Luc, Wagner, Clothilde, Munch, Marion, Renaud Picard, Benjamin, Grenet, Dominique, Olland, Anne, Greget, Michel, Enescu, Iulian, Bouilloud, Florence, Bonnette, Pierre, Guth, Axel, Bosco, Domenico, Mercier, Catherine, Rabilloud, Muriel, Berney, Thierry, Yves Benhamou, Pierre, Massard, Gilbert, Camilo, Coralie, Colin, Cyrille, Arnold, Cécile, Kessler, Romain, Kessler, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540675/ https://www.ncbi.nlm.nih.gov/pubmed/35403818 http://dx.doi.org/10.1111/ajt.17058 |
Ejemplares similares
-
Patients Treated for Central Airway Stenosis After Lung Transplantation Have Persistent Airflow Limitation
por: Mazzetta, Andrea, et al.
Publicado: (2019) -
Atypical hemolytic and uremic syndrome due to C3 mutation in pancreatic islet transplantation: a case report
por: Bahougne, Thibault, et al.
Publicado: (2020) -
Islets-on-Chip: A Tool for Real-Time Assessment of Islet Function Prior to Transplantation
por: Raoux, Matthieu, et al.
Publicado: (2023) -
Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol
por: Lablanche, Sandrine, et al.
Publicado: (2017) -
Reply: Comment on ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'
por: Renaud, Stéphane, et al.
Publicado: (2015)